1. Introduction

   • Martial G. Bourassa

   Interview 23 October 2012 Pages: 1 - 2

2. Clinical Pharmacology of Cilazapril

   • Cornelis H. Kleinbloesem
   • Peter van Brummelen
   • Ulf-W. Wlegand

   OriginalPaper 23 October 2012 Pages: 3 - 10

3. Clinical Pharmacodynamic Studies with Cilazapril and a Combination of Cilazapril and Propranolol

   • K. A. Erb
   • J. Essig
   • G. G. Belz

   OriginalPaper 23 October 2012 Pages: 11 - 17

4. Cilazapril

   • Thomas Szucs

   OriginalPaper 23 October 2012 Pages: 18 - 24

5. Effects of ACE Inhibition on Renal Haemodynamics in Essential Hypertension and Hypertension Associated with Chronic Renal Failure

   • R. A. Sánchez
   • R. A. Traballi
   • G. Long

   OriginalPaper 23 October 2012 Pages: 25 - 30

6. Antihypertensive Duration of Action of Cilazapril in Patients with Mild to Moderate Essential Hypertension

   • I. Kobrin
   • P. Güntzel
   • R. Zimlichman

   OriginalPaper 23 October 2012 Pages: 31 - 36

7. First Experience with Cilazapril in the Treatment of Sleep Apnoea-Related Hypertension

   • J. Mayer
   • J. H. Peter

   OriginalPaper 23 October 2012 Pages: 37 - 47

8. Enalaprilat, but not Cilazaprilat, Increases Inflammatory Skin Reactions in Guinea-Pigs

   • Rolf G. G. Andersson
   • Bengt E. Karlberg
   • Ulf Rosenqvist

   OriginalPaper 23 October 2012 Pages: 48 - 53

9. Cilazapril in Congestive Heart Failure

   • W. Kiowski
   • H. Drexler
   • H. Just

   OriginalPaper 23 October 2012 Pages: 54 - 61

10. Vascular Protection with Cilazapril

    • Jean Paul Clozel
    • Jerry S. Powell
    • Hans Rudolf Baumgartner

    OriginalPaper 23 October 2012 Pages: 62 - 67

11. Summary and Closing Remarks

    • Martial G. Bourassa

    Announcement 23 October 2012 Pages: 68 - 69